Suppr超能文献

乳酸林格氏液能与输血安全联用吗?

Can Ringer's lactate be used safely with blood transfusions?

作者信息

Lorenzo M, Davis J W, Negin S, Kaups K, Parks S, Brubaker D, Tyroch A

机构信息

Department of Surgery, University of California, San Francisco/Fresno Valley Medical Center, USA.

出版信息

Am J Surg. 1998 Apr;175(4):308-10. doi: 10.1016/s0002-9610(98)00011-7.

Abstract

BACKGROUND

Blood bank recommendations specify that Ringer's lactate solution (LR) should be avoided while transfusing blood. However, there are few studies either evaluating or quantifying increased coagulation during rapid infusion of LR and blood.

DESIGN AND METHODS

Whole blood (WB, n = 25) and packed red blood cells (PRBC, n = 26) were rapidly admixed with normal saline (NS), Lactate solution and LR with 1 g (LR-1), 2 g (LR-2), and 5 g (LR-5) CaCl2/L solutions for assessment of infusion time, filter weight, and clot formation.

RESULTS

No significant differences in infusion time or filter weight using WB or PRBC with NS or LR were seen. No significant difference in clot formation between NS and LR with WB or PRBC was found, but the presence of visible clot was increased in the LR-5 group (P = 0.013, WB, and P = 0.002, PRBC).

CONCLUSION

A comparison of LR and NS with rapid infusion rates of blood showed no significant difference between infusion time, filter weight and clot formation. Blood bank guidelines should be revised to allow the use of LR in the rapid transfusion of PRBC.

摘要

背景

血库建议指出,输血时应避免使用乳酸林格氏液(LR)。然而,很少有研究评估或量化快速输注LR和血液期间凝血增加的情况。

设计与方法

将全血(WB,n = 25)和浓缩红细胞(PRBC,n = 26)分别与生理盐水(NS)、乳酸溶液以及含有1 g(LR-1)、2 g(LR-2)和5 g(LR-5)氯化钙/升溶液的LR快速混合,以评估输注时间、滤器重量和凝血形成情况。

结果

使用WB或PRBC与NS或LR混合时,在输注时间或滤器重量方面未观察到显著差异。在使用WB或PRBC时,NS和LR之间在凝血形成方面未发现显著差异,但LR-5组中可见凝块的出现有所增加(WB组P = 0.013,PRBC组P = 0.002)。

结论

对LR和NS与快速输血速率进行比较,结果显示在输注时间、滤器重量和凝血形成方面无显著差异。血库指南应进行修订,以允许在快速输注PRBC时使用LR。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验